Cargando…
Biologics and surgical outcomes in Crohn’s disease: is there a direct relationship?
Despite significant advances in medical therapy in the management of Crohn’s disease (CD), surgery is still required in a significant proportion of patients and constitutes an important tool in treatment algorithms. Recently, more options of biological agents have been made available, and most patie...
Autores principales: | Quaresma, Abel Botelho, Yamamoto, Takayuki, Kotze, Paulo Gustavo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366403/ https://www.ncbi.nlm.nih.gov/pubmed/32728389 http://dx.doi.org/10.1177/1756284820931738 |
Ejemplares similares
-
Exploring the Relationship between Biologics and Postoperative Surgical Morbidity in Ulcerative Colitis: A Review
por: Quaresma, Abel Botelho, et al.
Publicado: (2021) -
Mesenchymal Stem Cells for Perianal Crohn’s Disease
por: Carvello, Michele, et al.
Publicado: (2019) -
Clinical utility of ustekinumab in Crohn’s disease
por: Kotze, Paulo Gustavo, et al.
Publicado: (2018) -
Impact of Preoperative Nutritional Status on the Incidence Rate of Surgical Complications in Patients With Inflammatory Bowel Disease With Vs Without Preoperative Biologic Therapy: A Case-Control Study
por: Yamamoto, Takayuki, et al.
Publicado: (2019) -
Preoperative use of anti-tumor necrosis factor therapy in Crohn's disease: promises and pitfalls
por: Kotze, Paulo Gustavo, et al.
Publicado: (2017)